Xiaoying Gu

Chinese Academy of Medical Sciences & Peking Union Medical College

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet(2020)10.1016/s0140-6736(20)31022-9

N/A

11.3DataRank · unranked

3663 citations

Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin +41 more

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

The Lancet(2020)10.1016/s0140-6736(20)30183-5

N/A

1.6DataRank · unranked

51651 citations

Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu +25 more

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The Lancet(2020)10.1016/s0140-6736(20)30566-3

N/A

1.5DataRank · unranked

29046 citations

Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu +14 more